Details
Stereochemistry | ACHIRAL |
Molecular Formula | CHCl3 |
Molecular Weight | 119.378 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC(Cl)Cl
InChI
InChIKey=HEDRZPFGACZZDS-UHFFFAOYSA-N
InChI=1S/CHCl3/c2-1(3)4/h1H
Molecular Formula | CHCl3 |
Molecular Weight | 119.378 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chloroform is a colorless, sweet-smelling, dense liquid and widely used industrial and laboratory solvent. The total global flux of chloroform through the environment is approximately 660 000 tonnes per year, and about 90% of emissions are natural in origin. Many kinds of seaweed produce chloroform, and fungi are believed to produce chloroform in soil. Chloroform is used as an industrial solvent and as an intermediate in the manufacture of polymeric materials. The major use of chloroformtoday is in the production of the refrigerant R-22, commonly used in the air conditioning business. Inhaled chloroform anesthesia was introduced in 1847 and Chloroform subsequently became the most widely used volatile anaesthetic, and was used in horses before the end of the 19th century. Pure chloroform is known to be decomposed by the air with the formation of hydrochloric acid, phosgene and carbon dioxide. Phosgene is also generated metabolically from chloroform, and liver and kidney damage can ensue from its production.
Originator
Approval Year
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
176 μg × min/mL |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: FEMALE food status: UNKNOWN |
|
293 μg × min/mL |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
86 min |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: FEMALE food status: UNKNOWN |
|
96 min |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: MALE food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Disc. AE: Loss of consciousness, Hypotension... AEs leading to discontinuation/dose reduction: Loss of consciousness Sources: Page: p.1,2Hypotension Respiratory depression (severe) Abdominal pain (severe) Vomiting Diarrhea Enterocolitis (severe) Erosive oesophagitis (severe) Gastritis erosive (severe) Ulceration (severe) Contact dermatitis ALT increased AST increased |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: Page: p.26 |
unknown Health Status: unknown Condition: anaesthesia Sources: Page: p.26 |
Disc. AE: Respiratory failure, Cardiac arrhythmias... AEs leading to discontinuation/dose reduction: Respiratory failure (grade 5) Sources: Page: p.26Cardiac arrhythmias (grade 5) Cardiac failure (grade 5) |
1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
Disc. AE: Dizziness, Intracranial pressure increase... AEs leading to discontinuation/dose reduction: Dizziness Sources: Intracranial pressure increase Nausea Headache |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
ALT increased | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
AST increased | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Contact dermatitis | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Diarrhea | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Hypotension | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Loss of consciousness | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Vomiting | Disc. AE | 30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Abdominal pain | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Enterocolitis | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Erosive oesophagitis | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Gastritis erosive | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Respiratory depression | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Ulceration | severe Disc. AE |
30 mL single, oral (max) Overdose Dose: 30 mL Route: oral Route: single Dose: 30 mL Sources: Page: p.1,2 |
healthy, 30 n = 1 Health Status: healthy Age Group: 30 Sex: F Population Size: 1 Sources: Page: p.1,2 |
Cardiac arrhythmias | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: Page: p.26 |
unknown Health Status: unknown Condition: anaesthesia Sources: Page: p.26 |
Cardiac failure | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: Page: p.26 |
unknown Health Status: unknown Condition: anaesthesia Sources: Page: p.26 |
Respiratory failure | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: Page: p.26 |
unknown Health Status: unknown Condition: anaesthesia Sources: Page: p.26 |
Dizziness | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
Headache | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
Intracranial pressure increase | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
Nausea | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
PubMed
Title | Date | PubMed |
---|---|---|
Herpes zoster and post-herpetic neuralgia--a clinical trial of aspirin in chloroform for anodyne. | 1998 Apr |
|
Purification and characterization of catalase from chard (Beta vulgaris var. cicla). | 2001 |
|
Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications. | 2001 |
|
Incidence of seed-borne fungi and aflatoxins in Sudanese lentil seeds. | 2001 |
|
Determination of ochratoxin A in red wine and vinegar by immunoaffinity high-pressure liquid chromatography. | 2001 Apr |
|
Benzene-extracted components are important for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression in human bronchial epithelial cells. | 2001 Apr |
|
The Bacillus subtilis yabQ gene is essential for formation of the spore cortex. | 2001 Apr |
|
First isolation and characterization of eight regioisomers for [60]fullerene-benzene bisadducts. | 2001 Apr 19 |
|
Synthesis and self-aggregation of cyclic alkynes containing helicene. | 2001 Apr 19 |
|
Long-term follow-up on keratocysts treated according to a defined protocol. | 2001 Feb |
|
Influence of N-terminal residue stereochemistry on the prolyl amide geometry and the conformation of 5-tert-butylproline type VI beta-turn mimics. | 2001 Feb |
|
Oxidative degradation study of nitrendipine using stability indicating, HPLC, HPTLC and spectrophotometric method. | 2001 Feb |
|
A liquid chromatographic method for the simultaneous determination of promethazine and three of its metabolites in plasma using electrochemical and UV detectors. | 2001 Feb |
|
Antibacterial activity of Punica granatum. | 2001 Feb |
|
Antibacterial activity of Barringtonia racemosa. | 2001 Feb |
|
Enhanced biodegradation of cyclotetramethylenetetranitramine (HMX) under mixed electron-acceptor condition. | 2001 Feb |
|
Estimation of potential lifetime cancer risks for trihalomethanes from consuming chlorinated drinking water in Taiwan. | 2001 Feb |
|
Rapid reductive destruction of hazardous organic compounds by nanoscale Fe0. | 2001 Feb |
|
Photocatalytic degradation of gaseous perchloroethylene: products and pathway. | 2001 Feb |
|
Carbon tetrachloride dechlorination by the bacterial transition metal chelator pyridine-2,6-bis(thiocarboxylic acid). | 2001 Feb 1 |
|
Reductive dechlorination of cis-1,2-dichloroethene and vinyl chloride by "Dehalococcoides ethenogenes". | 2001 Feb 1 |
|
Correlation of a specific mitochondrial phospholipid-phosgene adduct with chloroform acute toxicity. | 2001 Feb 21 |
|
Selective extraction of subunit D of the Na(+)-translocating methyltransferase and subunit c of the A(1)A(0) ATPase from the cytoplasmic membrane of methanogenic archaea by chloroform/methanol and characterization of subunit c of Methanothermobacter thermoautotrophicus as a 16-kDa proteolipid. | 2001 Feb 5 |
|
Effect of depletion of FtsY on spore morphology and the protein composition of the spore coat layer in Bacillus subtilis. | 2001 Feb 5 |
|
Formation and decomposition of chloroaromatic compounds in chlorine-containing benzene/oxygen flames. | 2001 Feb-Mar |
|
Direct measurements of hemoglobin interactions with liposomes using EPR spectroscopy. | 2001 Jan |
|
Invertebrate anesthesia. | 2001 Jan |
|
Methylation of neutral pseudotetrahedral zinc thiolate complexes: model reactions for alkyl group transfer to sulfur by zinc-containing enzymes. | 2001 Jan |
|
Drinking water contaminants and childhood leukemia. | 2001 Jan |
|
Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay. | 2001 Jan 1 |
|
Phenylisoserine: a versatile amino acid for the construction of novel beta-peptide structures. | 2001 Jan 10 |
|
Quantitative determination of marine toxins associated with diarrhetic shellfish poisoning by liquid chromatography coupled with mass spectrometry. | 2001 Jan 12 |
|
Occupational exposure to trihalomethanes in indoor swimming pools. | 2001 Jan 17 |
|
Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. | 2001 Jul 6 |
|
Biosynthesis of PHB tercopolymer by Bacillus cereus UW85. | 2001 Mar |
|
Isolation of genomic DNA from feathers. | 2001 Mar |
|
Surface modification of polyhydroxyalkanoate films and their interaction with human fibroblasts. | 2001 Mar 14 |
|
Photochemistry of the pi-extended 9,10-bis(1,3-dithiol-2-ylidene)-9,10-dihydroanthracene system: generation and characterisation of the radical cation, dication, and derived products. | 2001 Mar 2 |
|
Antiimplantation and pregnancy interruption efficacy of Rivea hypocrateriformis in the rat. | 2001 Mar 3 |
|
Fabrication of poly(phosphoester) nerve guides by immersion precipitation and the control of porosity. | 2001 May |
|
A controlled field experiment on groundwater contamination by a multicomponent DNAPL: creation of the emplaced-source and overview of dissolved plume development. | 2001 May |
|
Cytotoxic activity of Typhonium flagelliforme (Araceae). | 2001 May |
|
Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. | 2001 May |
|
Evaluation of diimine ligand exchange on Cu(I). | 2001 May 21 |
|
Rigorous interpretation of electronic density functions of axial and equatorial conformers of dimethylphosphinoylcyclohexane, 2-(dimethylphosphinoyl)-1,3,5-trithiane, and 2-(dimethylphosphinoyl)-1,3-dithiane-1,1,3,3-tetraoxide. | 2001 May 4 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:09:44 GMT 2023
by
admin
on
Fri Dec 15 15:09:44 GMT 2023
|
Record UNII |
7V31YC746X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
20701
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
||
|
WHO-VATC |
QN01AB02
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
||
|
NCI_THESAURUS |
C45386
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
||
|
IARC | Chloroform | ||
|
WHO-ATC |
N01AB02
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
||
|
CFR |
21 CFR 310.502
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
||
|
CFR |
21 CFR 700.18
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
35255
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
67-66-3
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
200-663-8
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
4363
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
1601383
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
56
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
m3412
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL44618
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
DTXSID1020306
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
SUB13331MIG
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
77361
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
SUB13333MIG
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
ALTERNATIVE | |||
|
C29815
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
D002725
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
1362698
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | RxNorm | ||
|
6212
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
7V31YC746X
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
100000080074
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
chloroform
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
7V31YC746X
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
CHLOROFORM
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
DB11387
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY | |||
|
SUB29129
Created by
admin on Fri Dec 15 15:09:44 GMT 2023 , Edited by admin on Fri Dec 15 15:09:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE TOXIC -> PARENT |
Renal tubular and hepatic necrosis in man.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |